Authors: SANDLER AN ARLANDER E FINUCANE BT TADDIO A CHAN V MILNER A CALLAHANENRIGHT SO FRIEDLANDER M MUZYKA D

Citation: An. Sandler et al., PHARMACOKINETICS OF 3 DOSES OF EPIDURAL ROPIVACAINE DURING HYSTERECTOMY AND COMPARISON WITH BUPIVACAINE, Canadian journal of anaesthesia, 45(9), 1998, pp. 843-849

Authors: ARLANDER E EKSTROM G ALM C CARRILLO JA BIELENSTEIN M BOTTIGER Y BERTILSSON L GUSTAFSSON LL

Citation: E. Arlander et al., METABOLISM OF ROPIVACAINE IN HUMANS IS MEDIATED BY CYP1A2 AND TO A MINOR EXTENT BY CYP3A4 - AN INTERACTION STUDY WITH FLUVOXAMINE AND KETOCONAZOLE AS IN-VIVO INHIBITORS, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 484-491

Authors: OSTERLUND A ARLANDER E WESTMAN L ERIKSSON LI LINDAHL SGE

Citation: A. Osterlund et al., VENTILATORY RESPONSE TO HYPERCARBIA AND HYPOXIA DURING 24-HOUR AFTER INTRATHECAL SAMERIDINE OR BUPIVACAINE, Anesthesiology, 87(3), 1997, pp. 807-807

Authors: ARLANDER E OST A STAHLBERG D LOFBERG R

Citation: E. Arlander et al., ROPIVACAINE GEL IN ACTIVE DISTAL ULCERATIVE-COLITIS AND PROCTITIS - APHARMACOKINETIC AND EXPLORATORY CLINICAL-STUDY, Alimentary pharmacology & therapeutics, 10(1), 1996, pp. 73-81